RE: Not all bad19 Jul 2018 10:46
Pom
True, but then why the drop in SP after the announcement that at least the product has been registered with now a proper timeline re FDA approval. all previous dates and projections fall by the way side.
I hope I am wrong, but it currently seems to me that until money has changed hands, this will just continue to be a traded share. This should be at a much higher value given what we have and where we now find ourselves, but the market just doesn't agree.
And although it is plain that the USA is maybe 5 x that of the EU. What does that actually mean, just the EU or does that consider all of Recordati territories including CIS, North Africa and Turkey which equates to about 550mill men.
Lets say that the ROW licenses surprisingly were agreed, all of this would far outstrip the USA in numbers and at reduced price and market penetration, I am sure that the USA would still be lacking. Not forgetting China, although I have have left that out due to time that may be taken to get it up n running.